Adaptive Biotechnologies Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +44.8% | +52.8% | +15.6% | +56.9% | +20.1% | -8.1% | +5.1% | +54.8% | |
| – | +25.4% | +13.2% | +1.1% | +118.8% | +17.5% | +30.5% | -4.6% | -1.0% | |
| – | +58.1% | +74.5% | +20.8% | +38.5% | +21.3% | -25.6% | +12.8% | +92.4% | |
| – | +22.4% | +80.6% | +64.2% | +22.6% | -0.4% | -13.9% | -15.7% | -8.9% | |
| – | +28.0% | +48.6% | +63.3% | +50.4% | +18.8% | -5.2% | -13.3% | -0.1% | |
| – | +29.1% | +64.6% | +62.0% | +37.3% | +4.3% | -1.8% | -16.3% | -2.5% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +154.1% | +225.6% | -16.1% | +1.7% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | -395.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.